New US$100,000 Prize
The Roux Prize rewards bold action to improve population health through disease burden evidence. Nominations close March 31, 2014.
Public financing of health in developing countries: a cross-national systematic analysis
Published in The Lancet, April 2010
Public financing of health by domestic governments nearly doubled between 1995 and 2006, according to IHME research. The study, Public financing of health in developing countries: a cross-national systematic analysis, also analyzes the effect of development assistance for health, gross domestic product, government size, debt relief, and HIV prevalence on government health spending from domestic sources. The study was conducted in collaboration with Harvard Medical School.
Domestic government spending on health doubled in low-income countries over 12 years to reach $18 billion in 2006. In southern and eastern sub-Saharan Africa, where governments receive significant health aid directly, the aid appears to be replacing domestic health spending instead of supplementing it. For every $1 spent in health aid, governments shifted between 43 cents and $1.14 of their own funds to other priorities. Conversely, in countries where non-governmental organizations receive most of the aid and then apply it to projects inside the country, government health spending appears to have increased. Here are some other highlights:
- Health spending has been taking up a growing share of overall government spending.
- Large parts of Latin America, the Middle East, and Asia have increased government commitment to health.
- Countries with large HIV epidemics are among the largest recipients of health aid, but they did not appear to increase government spending on health as a result of the aid.
The researchers analyzed spending data from developing countries and health aid data from agencies, multilateral institutions such as the World Health Organization (WHO) and the International Monetary Fund (IMF), and hundreds of nonprofit groups. They then employed advanced statistical techniques to test whether factors such as health aid, debt relief, national income, overall government spending, and HIV prevalence affect domestic health spending.
Using two distinct statistical models, the team analyzed government health expenditure data from WHO and IMF. Spending reports are often missing entire years’ worth of information, particularly among the poorest countries, and data from IMF and WHO can be difficult to reconcile.
They also tested different groups of countries and found that the results did not differ substantially across these groups.
By researching the relationship between development assistance for health and domestic health spending, IHME intends to help guide policies that will have the greatest possible impact on improving health. IHME has dedicated a segment of its research every year to track where funding allocated for health is being spent.
Recommendations for future work
In countries where domestic health spending has been shifted to other priorities, the researchers were unable to track where that funding went. In most cases, this is because governments do not report public financing by sector. The researchers also recommend these areas for future study:
- the capacity of developing countries to effectively receive and spend health aid
- case studies to understand why some countries that receive health aid spend more of their domestic budgets on health than others
- the effect of health aid on health outcomes
Citation: Lu C, Schneider MT, Gubbins P, Leach-Kemon K, Jamison D, Murray CJL. Public financing of health in developing countries: a cross-national systematic analysis. The Lancet. 2010 April 17; 375:1375–1387.
Data and Methods
Data for download. Public financing of health by region and country, 1995-2006 (347KB xls)
For additional information, visit our Global Health Data Exchange (GHDx). The GHDx includes data records with information on more than 200 countries.